SCHEMBL6167745

SCHEMBL6167745

Cc1ccn(C(C=O)N2CCN(c3ccc(F)cc3)CC2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
MAPT P10636 6/20 0.41
MAPK1 P28482 2/20 0.41
HTT P42858 2/20 0.41
RECQL P46063 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 5/20 0.39
ALDH1A1 P00352 2/20 0.39
GFER P55789 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
RAB9A P51151 1/20 0.37
KDM4E B2RXH2 1/20 0.37
POLB P06746 2/20 0.37
CYP3A4 P08684 1/20 0.37
MMP13 P45452 1/20 0.37
MMP14 P50281 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4019239 0.79 MEN1 (0.40) MEN1KMT2AMAPTMAPK1HTT
SCHEMBL4015182 0.79 DRD2 (0.40) MEN1KMT2AMAPTMAPK1HTT
SCHEMBL13739199 0.76 ALDH1A1 (0.53) MAPTMAPK1HTTLMNAALDH1A1
SCHEMBL4014716 0.75 GFER (0.40) MAPTMAPK1HTTLMNAALDH1A1
SCHEMBL4016082 0.74 DRD2 (0.38) MEN1KMT2AMAPTMAPK1HTT
SCHEMBL4459923 0.74 HSP90AA1 (0.40) MEN1KMT2AMAPTMAPK1HTT
SCHEMBL4013769 0.74 MAPT (0.40) MEN1KMT2AMAPTMAPK1HTT
SCHEMBL6168372 0.74 GFER (0.42) MEN1KMT2AMAPTMAPK1HTT
SCHEMBL4020863 0.73 CCR1 (0.44) MEN1KMT2AMAPTHTTLMNA
SCHEMBL4016465 0.70 ALDH1A1 (0.35) MEN1KMT2AMAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531822-A1 1-ARYL-4-SUBSTITUTED PIPERAZINE DERIVATIVES FOR USE AS CCR1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION AND IMMUNE DISORDERS Chemocentryx, Inc. (US) 2005-05-25 EP disclosed
WO-2003105853-A1 1-ARYL-4-SUBSTITUTED PIPERAZINES DERIVATIVES FOR USE AS CCR1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION AND IMMUNE DISORDERS CHEMOCENTRYX, INC. (US) 2003-12-24 WO disclosed